🇺🇸 FDA

Company profile · Sponsor

Telix

Telix Innovations

TLX · NYSE pharma NORTH MELBOURNE, C3, EU
Pipeline
24
Drugs
2
Patents
3

Quick answer

Telix (TLX) is a pharma company. headquartered in NORTH MELBOURNE, C3, EU. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 2 drugs, and 3 patents to this profile..

Company facts

Ticker TLX
Exchange NYSE
Company type pharma
Headquarters NORTH MELBOURNE, C3, EU
SEC CIK 0002007191

Pipeline (24)

Search pipeline →

  1. 177Lu-TLX250

    Telix

    ccRCC

    phase 3 other active

    1 trial

  2. 177Lu-TLX591

    Telix

    Metastatic Castration-resistant Prostate Cancer

    phase 3 small molecule active

    1 trial

  3. 68Ga-PSMA-11

    Telix

    PCA

    phase 3 small molecule active

    1 trial

  4. 89Zr-Girentuximab

    Telix

    Clear Cell Renal Cell Carcinoma

    phase 3 small molecule completed

    2 trials

  5. 89Zr-TLX250 PET/CT

    Telix

    Clear Cell Renal Cell Carcinoma

    phase 3 small molecule active

    1 trial

  6. Ga-68-PSMA-11

    Telix

    Prostate Cancer

    phase 3 small molecule terminated

    1 trial

  7. Standard of Care

    Telix

    Metastatic Prostate Cancer

    phase 3 small molecule terminated

    1 trial

  8. TLX-101-Tx + Lomustine

    Telix

    Neoplastic Disease

    phase 3 other active

    1 trial

  9. 177Lu girentuximab

    Telix

    Advanced Cancer

    phase 2 small molecule active

    1 trial

  10. 177Lu-DOTA-TLX591

    Telix

    Prostate Cancer

    phase 2 mab completed

    1 trial

  11. 4-L-[131I]iodo-phenylalanine (131I-IPA)

    Telix

    Glioblastoma Multiforme

    phase 2 other completed

    1 trial

  12. 89Zr-Girentuximab

    Telix

    Clear Cell Renal Cell Carcinoma (ccRCC)

    phase 2 small molecule active

    1 trial

  13. 89Zr-girentuximab for PET/CT imaging of CAIX positive tumors

    Telix

    Cervical Cancer

    phase 2 other terminated

    1 trial

  14. Fluciclovine F18

    Telix

    Prostate Adenocarcinoma

    phase 2 small molecule active

    1 trial

  15. PSMA PET/MR - Gallium-68 labeled PSMA-HBED-CC

    Telix

    Prostate Cancer

    phase 2 small molecule active

    1 trial

  16. Zirconium Zr 89 Girentuximab

    Telix

    Clear Cell Renal Cell Carcinoma

    phase 2 small molecule active

    1 trial

  17. 131I-IPA

    Telix

    Neoplastic Disease

    phase 1 small molecule active

    1 trial

  18. 153Sm-DOTMP

    Telix

    Bone Pain

    phase 1 small molecule active

    1 trial

  19. 177Lu-DOTA-TLX591

    Telix

    Metastatic Prostate Cancer

    phase 1 mab completed

    1 trial

  20. 177Lu-TLX250 and Peposertib

    Telix

    Solid Tumor, Adult

    phase 1 other active

    1 trial

  21. 64Cu-DOTA-TLX592

    Telix

    Metastatic Prostate Cancer

    phase 1 small molecule completed

    1 trial

  22. 68-Ga PSMA11

    Telix

    Prostate Adenocarcinoma

    phase 1 small molecule active

    1 trial

  23. 89Zr-DFOsq-olaratumab (89Zr-TLX300-CDx)

    Telix

    Soft Tissue Sarcoma

    phase 1 small molecule active

    1 trial

  24. 89Zr-Girentuximab

    Telix

    Clear Cell Renal Carcinoma

    phase 1 other completed

    1 trial

Drugs (2)

Search drugs →

  1. besilesomab

    SCINTIMUN

    V09HA03

  2. gallium ga-68 gozetotide

    ILLUCCIX

    INTRAVENOUS approved

Patents (3)

Search patents →

  1. US 12383636

    Marking precursor with squaric acid coupling

    Expires Mon Aug 07 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12329829

    Kit for radiolabelling with 68GA comprising a metal inhibitor

    Expires Mon Jun 12 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12121828

    Systems and methods of isolation of gallium-68

    Expires Mon Oct 17 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Telix?

Telix (TLX) is a pharma company. headquartered in NORTH MELBOURNE, C3, EU. listed on NYSE. NovaPharmaNews links 24 pipeline programs, 2 drugs, and 3 patents to this profile..

What pipeline programs does Telix sponsor?

We track 24 ClinicalTrials.gov-linked programs for Telix, including 177Lu-TLX250 and 23 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Telix company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.